{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040953","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.087241+00:00","generated_at":"2026-05-30T15:39:44.405699+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Calidi Biotherapeutics enters $5.1M ATM equity offering with Ladenburg Thalmann","bullets":["Company may sell up to $5.1M of common stock through ATM facility with Ladenburg Thalmann.","Commission of 3.0% on gross proceeds; expenses up to $50k reimbursable.","Shares sold at market prices; offering pursuant to effective S-3 registration statement.","Company not obligated to sell any shares; can suspend at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040953","json":"https://secwatch.observer/filing/0001493152-24-040953.json","markdown":"https://secwatch.observer/filing/0001493152-24-040953.md","text":"https://secwatch.observer/filing/0001493152-24-040953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/0001493152-24-040953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224040953/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T15:39:44.405699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}